top of page
MEDIA CENTER
Industry Articles and Media Interviews
IN THE NEWS:
What Precision Medicine Might Mean for Your Rheumatoid Arthritis Journey
The Journey to Find the Right Treatment for Rheumatoid Arthritis
Personalizing Your Rheumatoid Arthritis Treatment: 5 Questions to Ask Your Doctor
Social Media Connects, Informs Rheumatologists
Post-streptococcal reactive arthritis (PSRA): What to know
PODCAST, YOUTUBE & SOCIAL MEDIA GUEST APPEARANCES
SCIENTIFIC PAPERS
Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases
Myocardial Microvascular Dysfunction in Rheumatoid Arthritis
Current Perspectives On Emerging Biomarkers For Rheumatoid Arthritis-Associated Interstitial Lung Disease
Myocardial Inflammation, Measured Using 18-Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography, Is Associated With Disease Activity in Rheumatoid Arthritis
Low Skeletal Muscle Mass and Risk of Functional Decline in Elderly Community-Dwelling Women: The Prospective EPIDOS Study
Indicators of Walking Speed in Rheumatoid Arthritis: Relative Influence of Articular, Psychosocial, and Body Composition Characteristics
Precision Medicine for Rheumatoid Arthritis: The Right Drug for the Right Patient—Companion Diagnostics
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study
IgA Antibodies Directed Against Citrullinated Protein Antigens Are Elevated in Patients With Idiopathic Pulmonary Fibrosis
Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation
bottom of page